Associate Director, Government Pricing
Model NFull Time
Expert & Leadership (9+ years)
Candidates must possess a Bachelor's degree and ten years of managed markets experience in the pharmaceutical or biotech industry, or a Master's degree and eight years of experience. A minimum of 5 years of direct government price reporting experience is required, along with experience with CAR-T therapies. Expertise in government pricing regulations and operations for a broad product portfolio is essential, as are advanced skills in Model N, Microsoft Excel, Word, and PowerPoint. Understanding of processes across functional areas such as Channel/Trade, Commercial Contracting, Government Contracting, Patient Assistance, Commercial Rebates, Government Rebates, and Chargebacks is necessary, along with project management, cross-functional team leadership, and system implementation experience.
The Associate Director will oversee assigned day-to-day operations for Government Programs & Pricing (GPP) across Gilead’s US portfolio. This role requires effective collaboration with Legal, Contract Operations, Trade Operations, Compliance, and IT, utilizing strong communication and influencing skills to drive business value. The position involves managing multiple industry relationships, navigating information to provide reliable data, and influencing senior management with recommended solutions. Responsibilities include recognizing and interpreting business issues/opportunities, analyzing them, and implementing or negotiating solutions with external parties, while managing direct reports and others in related areas.
Develops and commercializes biopharmaceuticals
Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.